Cisd2 haploinsufficiency, namely a half dose of Cisd2, is insufficient, and this state accelerates WD-induced liver pathogenesis in the liver and exacerbates its progression toward NASH. The gene discussed is CISD2; the disease is metabolic dysfunction-associated steatohepatitis.